Hematology and Oncology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Parameswaran Hari, M.D., M.R.C.P., M.S.

Armand Quick – William Stapp Professor of Hematology

Section Head, Hematological Malignancies

Director, Adult Blood and Marrow Transplant Program



Parameswaran Hari, M.D., M.R.C.P., M.S., is the Armand J. Quick/William F. Stapp Professor of Hematology at Medical College of Wisconsin.  Dr. Hari serves as Director of the Adult Blood and Marrow Transplant Program (BMT) at Froedtert Hospital and Section Head, Hematologic Malignancies and Transplantation,  in the Division of Hematology and Oncology in the Department of Medicine. After medical school in India, he completed training in Internal Medicine and Hematology at premier institutions in United Kingdom and then in Medical Oncology and Transplantation at the Medical College of Wisconsin. His primary clinical interests are in allogeneic hematopoietic stem cell transplantation, plasma cell disorders -- multiple Myeloma, Amyloidosis and other monoclonal gammopathies. Dr. Hari is also Scientific Director of the plasma cell disorders and lymphoma working committees of the Center for International Blood and Marrow Transplant Research (CIBMTR).


Selected Publications Last 2 years:

  1. Devine SM, Carter S, Soiffer RJ, Pasquini MC, Hari PN, et al. Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303.Biol Blood Marrow Transplant. 2011 Feb 12.
  2. Olteanu H, Harrington AM, Hari P, Kroft SH. CD200 expression in plasma cell myeloma. Br J Haematol. 2011 Jan 3
  3. Reece DE, Vesole DH, Shrestha S …. And Hari PN. Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study. Clin Lymphoma Myeloma Leuk. 2010 Dec 1;10(6):458-63
  4. Shidham VB, Hunt B, Jardeh SS, Barboi AC, Devata S, Hari P. Performing and processing FNA of anterior fat pad for amyloid. J Vis Exp. 2010 Oct 30;(44). pii: 174
  5. Joshua TV, Rizzo JD, Zhang MJ, Hari PN, …….., Horowitz MM. Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer. 2010 Jul 15;116(14):3469-76.
  6. Kumar SK, Flinn I, Noga SJ, Hari P, …….., Richardson PG, Rajkumar SV. Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study. Leukemia. 2010 Jul;24(7):1350-
  7. Lazarus HM, Zhang MJ, Carreras J, ………..Winter JN, van Besien K, Vose JM, Hari PN. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biol Blood Marrow Transplant. 2010 Jan;16(1):35-45.
  8. Hari PN, Majhail NS, Zhang MJ, et al. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402.
  9. Fenske TS, Hari PN, Carreras J, ………Rizzo JD, van Besien K, Lazarus HM, Vose JM. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant. 2009 Nov;15(11):1455-64.
  10. Hari P, …. Et al ; Is The International Staging System Superior To The Durie Salmon Staging System? A Comparison In The Multiple Myeloma Patients Undergoing Autologous Transplant. Leukemia. 2009 Aug;23(8):1528-34.
  11. Van Besien K, Carreras JC, … Hari P; Unrelated donor Hematopoietic Cell Transplantation for NHL: Long term outcomes. Biol Blood Marrow Transplant. 2009 May;15(5):554-63
  12. Rotta M, Storer BE, ……….Hari P, Storb RF, Maloney DG. Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood. 2009 Apr 2;113(14):3383-91.
  13. Bashey A, Perez W,….Hari P, Comparison of Twin and Autologous Transplants for Multiple Myeloma Biol Blood Marrow Transplant. 2008 Oct;14(10):1118-24.
  14. Kumar S, …… Hari P, Comparable outcomes in Non-Secretory and Secretory Multiple myeloma after autologous stem cell transplantation. Biol Blood Marrow Transplant. 2008 Oct;14(10):1134-40
  15. Drobyski WR, Hari P, Keever-Taylor C et al. Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant. 2009 Jan;43(2):169-77.

View our Clinical Trials

Best Doctors® and the star-in-cross logo are registered trademarks of Best Doctors, Inc. in the United States and other countries.

 

webmaster@mcw.edu
© 2014 Medical College of Wisconsin
Page Updated 02/11/2014